Due to the central role of immunotherapy in the investigation of cancer treatment, further investigation including research strategies of modulation of the immune tumor microenvironment, such as the GBM-associated and hypoxia-induced HIF-1α/VEGF pathways would contribute to the treatment of GBM. Here, HIF1A is linked to glioblastoma.